Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHADONE Cause Malignant neoplasm progression? 43 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Malignant neoplasm progression have been filed in association with METHADONE (METHADONE HYDROCHLORIDE). This represents 0.2% of all adverse event reports for METHADONE.

43
Reports of Malignant neoplasm progression with METHADONE
0.2%
of all METHADONE reports
25
Deaths
20
Hospitalizations

How Dangerous Is Malignant neoplasm progression From METHADONE?

Of the 43 reports, 25 (58.1%) resulted in death, 20 (46.5%) required hospitalization, and 3 (7.0%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHADONE. However, 43 reports have been filed with the FAERS database.

What Other Side Effects Does METHADONE Cause?

Drug dependence (5,739) Toxicity to various agents (4,586) Drug abuse (4,480) Overdose (3,472) Pain (2,754) Death (2,716) Emotional distress (2,388) Drug withdrawal syndrome (2,127) Foetal exposure during pregnancy (1,759) Drug withdrawal syndrome neonatal (1,458)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which METHADONE Alternatives Have Lower Malignant neoplasm progression Risk?

METHADONE vs METHAMPHETAMINE METHADONE vs METHENAMINE HIPPURATE METHADONE vs METHIMAZOLE METHADONE vs METHOCARBAMOL METHADONE vs METHOHEXITAL

Related Pages

METHADONE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression METHADONE Demographics